Google Health goes live

Share this article:
Google Health goes live
Google Health goes live
Google yesterday launched its long-awaited online personal health record service dubbed Google Health.

The web portal, found at google.com/health, is the latest entrant into a field of several, including WebMD, Microsoft and Revolution Health, offering personal health records online.

Earlier this year, Google and the Cleveland Clinic conducted a 2-month pilot of the service. The project, limited to 1,600 patients, was quickly oversubscribed.

Google said it will not be selling ads on Google Health and what information is shared with doctors, clinics or pharmacies is controlled by the individual.

More than two dozen companies and institutions announced partnerships with Google Health, including Walgreens, CVS, the American Heart Association, Quest Diagnostics, Beth Israel Deaconess Medical Center and the Cleveland Clinic.

Marissa Mayer, Google's VP of search products, told the New York Times that Google Health represents a “large ongoing initiative” by the company, which she said she hoped would eventually include “thousands of partners and millions of users.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...